Cargando…
Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer
Intraperitoneal (i.p.) tumor dissemination and the consequent malignant ascites remain unpredictable and incurable in patients with gastrointestinal (GI) cancer, and practical advances in diagnosis and treatment are urgently needed in the clinical settings. Here, we explored tumor biological and imm...
Autores principales: | Ozawa, Hiroki, Imazeki, Hiroshi, Ogiwara, Yamato, Kawakubo, Hirofumi, Fukuda, Kazumasa, Kitagawa, Yuko, Kudo-Saito, Chie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681022/ https://www.ncbi.nlm.nih.gov/pubmed/34902741 http://dx.doi.org/10.1016/j.tranon.2021.101307 |
Ejemplares similares
-
Targeting Oncoimmune Drivers of Cancer Metastasis
por: Kudo-Saito, Chie, et al.
Publicado: (2021) -
CD11b(+)CTLA4(+) myeloid cells are a key driver of tumor evasion in colorectal cancer
por: Imazeki, Hiroshi, et al.
Publicado: (2021) -
Laparoscopic and endoscopic cooperative surgery for gastric cancer mimicking a submucosal tumor
por: Ozawa, Hiroki, et al.
Publicado: (2020) -
Gastrointestinal stromal tumor coexisting with disseminated peritoneal leiomyomatosis
por: Akamine, Kenri, et al.
Publicado: (2019) -
Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells
por: Sako, Hiroyuki, et al.
Publicado: (2014)